PFIZER INC Goodwill, Other Increase (Decrease)
PFIZER INC (PFE) reported Goodwill, Other Increase (Decrease) of -$204.00 million for the 6-month period ending 2020-06-28, per its 10-Q filed 2020-08-06.
Discontinued › Notes › Intangible Assets › Goodwill and Other
us-gaap:GoodwillOtherIncreaseDecrease · last filed 2020-08-06
- PFIZER INC goodwill, other increase (decrease) for the quarter ending 2020-06-28 was -$53.00M.
- PFIZER INC goodwill, other increase (decrease) for the quarter ending 2020-03-29 was -$151.00M, a 298.68% decline year-over-year.
- PFIZER INC goodwill, other increase (decrease) for the quarter ending 2019-12-31 was -$46.00M.
- PFIZER INC goodwill, other increase (decrease) for the quarter ending 2019-09-29 was -$64.00M.
- PFIZER INC goodwill, other increase (decrease) for fiscal 2019 was -$169.00M.
- PFIZER INC goodwill, other increase (decrease) for fiscal 2018 was -$2.54B, a 402.50% decline from fiscal 2017.
- PFIZER INC goodwill, other increase (decrease) for fiscal 2017 was $840.00M.
- PFIZER INC goodwill, other increase (decrease) for fiscal 2016 was -$162.00M.
| Period end | Goodwill, Other Increase (Decrease) 3 month | Goodwill, Other Increase (Decrease) 6 month | Goodwill, Other Increase (Decrease) 9 month | Goodwill, Other Increase (Decrease) 12 month |
|---|---|---|---|---|
| 2020-06-28 | -$53.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$204.00M 10-Q · filed 2020-08-06 | -$250.00M derived: sum of 3 quarters · filed 2020-08-06 | -$314.00M derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-29 | -$151.00M 10-Q · filed 2020-05-07 | -$197.00M derived: sum of 2 quarters · filed 2020-05-07 | -$261.00M derived: sum of 3 quarters · filed 2020-05-07 | -$396.00M derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | -$46.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$110.00M derived: sum of 2 quarters · filed 2020-02-27 | -$245.00M derived: sum of 3 quarters · filed 2020-02-27 | -$169.00M 10-K · filed 2020-02-27 |
| 2019-09-29 | -$64.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$199.00M derived: sum of 2 quarters · filed 2019-11-07 | -$123.00M 10-Q · filed 2019-11-07 | -$2.33B derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | -$135.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$59.00M 10-Q · filed 2019-08-08 | -$2.26B derived: sum of 3 quarters · filed 2020-02-27 | -$2.48B derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | $76.00M 10-Q · filed 2019-05-09 | -$2.13B derived: sum of 2 quarters · filed 2020-02-27 | -$2.35B derived: sum of 3 quarters · filed 2020-02-27 | -$2.91B derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | -$2.20B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$2.42B derived: sum of 2 quarters · filed 2020-02-27 | -$2.98B derived: sum of 3 quarters · filed 2020-02-27 | -$2.54B 10-K · filed 2020-02-27 |
| 2018-09-30 | -$221.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$779.00M derived: sum of 2 quarters · filed 2018-11-08 | -$338.00M 10-Q · filed 2018-11-08 | -$464.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-07-01 | -$558.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$117.00M 10-Q · filed 2018-08-09 | -$243.00M derived: sum of 3 quarters · filed 2019-02-28 | $316.00M derived: sum of 4 quarters · filed 2019-02-28 |
| 2018-04-01 | $441.00M 10-Q · filed 2018-05-10 | $315.00M derived: sum of 2 quarters · filed 2019-02-28 | $874.00M derived: sum of 3 quarters · filed 2019-02-28 | $1.15B derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-12-31 | -$126.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $433.00M derived: sum of 2 quarters · filed 2019-02-28 | $704.00M derived: sum of 3 quarters · filed 2019-02-28 | $840.00M 10-K · filed 2019-02-28 |
| 2017-10-01 | $559.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $830.00M derived: sum of 2 quarters · filed 2017-11-09 | $966.00M 10-Q · filed 2017-11-09 | $180.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-07-02 | $271.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-10 | $407.00M 10-Q · filed 2017-08-10 | -$379.00M derived: sum of 3 quarters · filed 2018-02-22 | -$287.00M derived: sum of 4 quarters · filed 2018-02-22 |
| 2017-04-02 | $136.00M 10-Q · filed 2017-05-11 | -$650.00M derived: sum of 2 quarters · filed 2018-02-22 | -$558.00M derived: sum of 3 quarters · filed 2018-02-22 | |
| 2016-12-31 | -$786.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$694.00M derived: sum of 2 quarters · filed 2018-02-22 | -$162.00M 10-K · filed 2018-02-22 | |
| 2016-10-02 | $92.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $624.00M 10-Q · filed 2016-11-10 | ||
| 2016-07-03 | $532.00M 10-Q · filed 2016-08-11 | |||
| 2015-12-31 | -$1.15B 10-K · filed 2017-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |